New Leaf Venture Partners is a venture capital firm in New York focused on investments in healthcare technology companies. Founded 2005 in New York, United States by James Niedel, Jeani Delagardelle, Philippe Chambon, Ronald Hunt, and Vijay Lathi, this venture capital firm invests in debt, early stage ventures, late stage ventures and private equity. Its portfolio companies include Iterum Therapeutics, Aptinyx, Kyruus, AiCure, and Edgewise Therapeutics. As of February 2020, New Leaf Venture Partners has made 155 investments. Their most recent investment was on Nov 7, 2019, when AiCure raised $24.5M. New Leaf Venture Partners has had 39 exits, the most notable of which include Alector, Aptinyx, and Wave Life Sciences. The company has raised four funds, their latest being New Leaf Ventures IV. The company specifically focuses on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.